Latest news
CervoMed granted Innovation Passport for neflamapimod in UK - thepharmaletter.comthepharmaletter.com · Wed, 05 Aug 2026 13:17:34 GMTBeOne Medicines secures UK innovation passport for HCC therapy - PharmaTimesPharmaTimes · Wed, 05 Aug 2026 09:59:35 GMTInnovation Passports for Liver Cancer and Dementia Treatm... - politicsuk.compoliticsuk.com · Wed, 05 Aug 2026 08:04:23 GMTCervoMed’s neflamapimod gains UK Innovation Passport - TipRanksTipRanks · Tue, 04 Aug 2026 13:18:13 GMTCervoMed granted UK Innovation Passport for neflamapimod in dementia with Lewy bodies - TradingViewTradingView · Tue, 04 Aug 2026 11:53:00 GMTNeflamapimod granted UK Innovation Passport to speed development for dementia with Lewy bodies treatment - PluangPluang · Tue, 04 Aug 2026 09:37:24 GMTCervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 09:15:00 GMTThe Innovative Licensing and Access Pathway grants Innovation Passports to investigational products for cancer and dementia - GOV.UKGOV.UK · Tue, 04 Aug 2026 08:56:29 GMT